Skip to main content

Table 3 Prevalence (and rank order) of diagnosis groups by gender and age group

From: The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort study

Diagnosis group total
(n = 3,189)
female
(n = 1,891)
male
(n = 1,298)
age 65-74
(n = 1,827)
age 75-84
(n = 1,362)
Hypertension 77.9% (1) 77.5% (1) 78.4% (1) 74.5% (1) 82.4% (1)
Lipid metabolism disorders 58.5% (2) 57.0% (2) 60.8% (2) 60.5% (2) 56.0% (2)
Chronic low back pain 49.5% (3) 55.2% (3) 41.1% (5) 48.3% (3) 51.0% (3)
Joint arthrosis§ 43.3% (4) 48.9% (4) 35.3% (6) 39.4% (4) 48.7% (4)
Diabetes mellitus§ 37.6% (5) 33.3% (6) 43.8% (4) 38.8% (5) 36.0% (6)
Thyroid dysfunction§ 33.8% (6) 43.5% (5) 19.6% (13) 35.8% (6) 31.1% (7)
Chronic ischemic heart disease§ 31.4% (7) 22.2% (12) 44.7% (3) 27.8% (7) 36.1% (5)
Cardiac arrhythmias§ 26.9% (8) 23.5% (9) 31.9% (7) 24.0% (9) 30.8% (8)
Asthma/Chronic obstructive pulmonary disease§ 24.2% (9) 23.1% (10) 25.7% (9) 24.2% (8) 24.2% (10)
Lower limb varicosis§ 23.3% (10) 28.8% (8) 15.2% (17) 21.7% (10) 25.3% (9)
Osteoporosis§ 19.8% (11) 28.9% (7) 6.6% (27) 17.5% (13) 23.0% (11)
Severe vision reduction§ 18.9% (12) 19.5% (13) 18.2% (14) 16.2% (15) 22.7% (12)
Cancers§ 18.3% (13) 15.5% (14) 22.4% (12) 17.6% (12) 19.3% (13)
Depression§ 17.8% (14) 22.6% (11) 10.6% (22) 18.6% (11) 16.7% (17)
Purine/pyrimidine metabolism disorders/Gout 17.3% (15) 12.9% (18) 23.7% (10) 16.3% (14) 18.7% (14)
Atherosclerosis/PAOD§ 16.7% (16) 12.0% (19) 23.4% (11) 15.2% (16) 18.6% (15)
Intestinal diverticulosis§ 14.5% (17) 15.5% (14) 13.0% (20) 14.5% (18) 14.5% (18)
Neuropathies§ 14.7% (18) 13.0% (17) 17.3% (15) 15.1% (17) 14.2% (20)
Cardiac insufficiency§ 13.1% (19) 11.8% (20) 15.0% (19) 9.6% (22) 17.7% (16)
Chronic gastritis/GERD# 12.9% (20) 13.6% (16) 11.9% (21) 14.0% (19) 11.5% (23)
Cerebral ischemia/Chronic stroke§ 11.8% (21) 9.5% (22) 15.1% (18) 9.9% (21) 14.4% (19)
Prostatic hyperplasia 11.4% (22) - 27.9% (8) 10.5% (20) 12.6% (22)
Renal insufficiency§ 10.7% (23) 7.1% (27) 15.8% (16) 8.2% (24) 14.0% (21)
Cardiac valve disorders§ 9.4% (24) 8.8% (23) 10.3% (23) 8.0% (26) 11.3% (24)
Chronic cholecystitis/Gallstones 7.9% (25) 8.3% (25) 7.2% (26) 6.7% (28) 9.5% (25)
Dizziness§ 7.7% (26) 8.7% (24) 6.3% (29) 6.7% (28) 9.1% (27)
Liver diseases§ 7.7% (27) 6.8% (28) 9.0% (25) 8.7% (23) 6.4% (29)
Haemorrhoids 7.5% (28) 5.6% (30) 10.3% (23) 8.1%(25) 6.7% (28)
Urinary incontinence§ 7.2% (29) 9.9% (21) 3.3% (36) 5.6% (30) 9.3% (26)
Somatoform disorders§ 6.1% (30) 7.7% (26) 3.7% (34) 7.0% (27) 4.9% (32)
Insomnia# 5.6% (31) 5.1% (33) 6.2% (30) 5.4% (32) 5.7% (31)
Severe hearing loss§ 5.2% (32) 4.2% (36) 6.8% (28) 4.7% (34) 6.0% (30)
Allergies# 4.9% (33) 6.0% (29) 3.4% (35) 5.8% (29) 3.8% (36)
Obesity# 4.8% (34) 4.8% (35) 4.9% (33) 5.5% (31) 3.9% (35)
Anemias§ 4.3% (35) 3.1% (38) 5.9% (31) 3.9% (38) 4.8% (33)
Rheumatoid arthritis/Chronic polyarthritis§ 4.2% (36) 5.6% (31) 2.2% (39) 3.9% (37) 4.6% (34)
Anxiety§ 4.1% (37) 5.3% (32) 2.2% (39) 4.7% (34) 3.2% (37)
Psoriasis§ 3.6% (38) 2.7% (39) 5.0% (32) 4.3% (36) 2.8% (39)
Migraine/chronic headache§ 3.5% (39) 4.9% (34) 1.5% (41) 5.0% (33) 1.5% (41)
Noninflammatory gynaecological problems 2.0% (40) 3.4% (37) - 2.5% (39) 1.4% (42)
Parkinson's disease§ 1.9% (41) 1.4% (40) 2.8% (37) 1.3% (41) 2.9% (38)
Urinary tract calculi 1.8% (42) 1.3% (41) 2.6% (38) 1.6% (40) 2.1% (40)
Hypotension# 0.5% (43) 0.5% (42) 0.4% (43) 0.4% (42) 0.6% (43)
Sexual dysfunction# 0.2% (44) - 0.5% (42) 0.3% (43) -
Tobacco abuse# 0.1% (45) 0 (43) 0.2% (44) 0.1% (44) -
Dementias* - - - - -
  1. § used for patient inclusion; # not part of the standardized data collection at baseline, * exclusion-criterion;n: number of cases; GERD: gastroesophageal reflux disease; PAOD: peripheral arterial occlusive disease